Pacira reported 35.68 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Astellas Pharma 9.41 6.06 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Cara Therapeutics 0.49 27.28 Mar/2026
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 29.43 4.9 Jun/2026
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
Novo Nordisk 10.17 2.61 Jun/2026
Pacira 35.68 2.9 Jun/2026
Perrigo 27.45 31.51 Mar/2026
Pfizer 11.48 2.16 Jun/2026
Supernus Pharmaceuticals 65.37 21.16 Jun/2026
Teva Pharmaceutical Industries 24.6 14.53 Jun/2026
Xeris Pharmaceuticals 76.05 2.37K Mar/2026
Zoetis 10.58 8.22 Jun/2026